BusinessATI Physical Therapy: Healthcare Experts Discuss Alternatives to the Opioid CrisisBy Nasdaq OMXJan 29, 2018, 10:14 PM UTC
BusinessVeritas and Cannevert Complete Prestudy Visit of the Puerto Rico Clinical Trial FacilityBy Nasdaq OMXDec 29, 2017, 8:05 AM UTC
BusinessUS Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm CannevertBy Nasdaq OMXNov 28, 2017, 8:05 AM UTC
BusinessElite Pharmaceuticals Files ANDA for Oxycodone Hydrochloride Extended ReleaseBy Nasdaq OMXSep 20, 2017, 12:38 PM UTC
BusinessNEW REPORT FROM GRANTMAKERS IN AGING EXPLORES IMPACT OF THE OPIOID EPIDEMIC ON RURAL AGINGBy Nasdaq OMXAug 24, 2017, 12:00 PM UTC
BusinessTrevena Attends National Institutes of Health Meeting to Discuss Development of Novel, Improved Pain MedicationsBy Nasdaq OMXJun 20, 2017, 8:01 PM UTC
BusinessBioCorRx Selects Covance for Non-Clinical Studies, Announces the Addition of Dr. Bal S. Brar to its Drug Development Team, Plans Pre-IND Meeting with FDABy Nasdaq OMXNov 28, 2016, 11:00 AM UTC
